Skip to main content
SpringerLink
Log in

Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The effect of humidity on the physicochemical properties of amorphous forms of cimetidine was investigated using differential scanning calorimetry, isothermal microcalorimetry, and x-ray diffraction analysis. Amorphous forms were obtained by the melting (amorphous form M [AM]) and the cotton candy (amorphous form C [AC]) methods. Thermal behaviors of AM and AC with or without seed crystals were measured using an isothermal microcalorimeter under various conditions of relative humidity (RH) and temperature, respectively. The crystallization kinetics of amorphous solids was analyzed based on 10 kinds of solid-state reaction models. AM transformed into form A at 11% RH, 50°C but transformed into a mixture of form A and monohydrate at 51% and 75% RH at 25°C. The mean crystallization times (MCTs) of the heat flow curve of AM and AC at 11% RH, 50°C were 47.82 and 32.00 hours, respectively, but at 11% RH, 25°C both were more than 4320 hours. In contrast, AC transformed into form A under all storage conditions. The MCTs of AC at 51% and 75% RH were 29.61 and 11.81 hours, respectively; whereas the MCTs of AM were 46.79 and 15.52 hours, respectively. The crystallization of amorphous solids followed the three-dimensional growth of nuclei (Avrami equation) with an induction period (IP). The IP for AM at 11% RH, 50°C was more than 2 times that for AC, but the difference in the crystal growth rate constant (CR) between AC and AM was within 10%. The IP for AM at 75% RH, 25°C was reduced to only 10% of the IP at 51% RH with increasing humidity, but the CR did not change significantly. In contrast, the IP for AC was slightly reduced at 75% RH compared with 51% RH, but the CR was about 5 times greater. At 75% RH, 25°C, the IP and CR of AM were about one-fourth the values of AC. This result suggests that the crystallization process consists of an initial stage during which the nuclei are formed and a final stage of growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Food and Drug Administration. Guidelines: manufacturing and controls for INDs and NDAs. Quoted by: Pharm Tech Japan. 1985; 1: 835–850.

    Google Scholar 

  2. Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci. 1975; 64: 1269–1288.

    Article  PubMed  CAS  Google Scholar 

  3. Otsuka M, Matsuda Y. Polymorphism, pharmaceutical aspects. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Vol 12. New York, NY: Marcel Dekker; 1995: 305–326.

    Google Scholar 

  4. Briggner L, Buckton G, Bystrom K, Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm. 1994; 105: 125–135.

    Article  CAS  Google Scholar 

  5. Sebhatu T, Angberg M, Ahlneck C. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int J Pharm. 1994; 104: 135–144.

    Article  CAS  Google Scholar 

  6. Angberg M, Nyström C, Castensson S. Evaluation of heatconduction microcalorimetry in pharmaceutical stability studies, V: a new approach for continuous measurements in abundant water vapour. Int J Pharm. 1992; 81: 153–167.

    Article  CAS  Google Scholar 

  7. Sheridan PL, Buckton G, Storey DE. Development of a flow microcalorimetry method for the assessment of surface properties of powders. Pharm Res. 1995; 12: 1025–1030.

    Article  PubMed  CAS  Google Scholar 

  8. Buckton G, Darcy P, Greenleaf D, Holbrook P. The use of isothermal microcalorimetry in the study of changes in crystallinity of spraydried salbutamol sulphate. Int J Pharm. 1995; 116: 113–118.

    Article  CAS  Google Scholar 

  9. Aso Y, Yoshioka S, Otsuka T, Kojima S. The physical stability of amorphous nifedipine determined by isothermal microcalorimetry. Chem Pharm Bull. 1995; 43: 300–303.

    CAS  Google Scholar 

  10. Rat M, Guillaume P, Wilker S, Pantel G. Practical application of microcalorimetry to the stability of propellants. Workshop Microcalorim Energ Mater. Defence Research Agency: Sevenoaks, UK. 1997: V1-V18.

    Google Scholar 

  11. Mimura H, Kitamura S, Koda S. Evaluation of drug stability by isothermal microcalorimetry. Netsu Sokutei. 1998; 25(4): 92–96.

    CAS  Google Scholar 

  12. Giron D. Thermal analysis, microcalorimetry and combined techniques for the study of pharmaceuticals. J Therm Anal Calorim. 1999; 56(3): 1285–1304.

    Article  CAS  Google Scholar 

  13. Du W, Li X, Wang B, Zhang Y. A study on the interaction between cisplatin and urease. Thermochim Acta. 1999; 333(2): 109–114.

    Article  CAS  Google Scholar 

  14. Beezer A, Gaisford S, Hills AK, Mitchell JC. Pharmaceutical microcalorimetry: applications to long-term stability studies. Int J Pharm. 1999; 179(2): 159–165.

    Article  PubMed  CAS  Google Scholar 

  15. Runge FE, Heger R. Use of microcalorimetry in monitoring stability. Example: vitamin A esters. J Agric Food Chem. 2000; 48(1): 47–55.

    Article  PubMed  CAS  Google Scholar 

  16. Tompa AS Jr, Bryant WF. Microcalorimetry and DSC study of the compatibility of energetic materials. Proc Workshop Microcalorim Energ Mater 2nd. Defence Research Agency: Sevenoaks, UK. 1999; Q1-Q21.

    Google Scholar 

  17. Phipps MA, Mackin LA. Application of isothermal calorimetry in solid state drug development. Pharm Sci Technol Today. 2000; 3(1): 9–17.

    Article  PubMed  CAS  Google Scholar 

  18. Shibata M, Kokubo H, Morimoto K, Morisaka K, Ishida T, Inoue M. X-ray structural studies and physicochemical properties of cimetidine polymorphism. J Pharm Sci. 1983; 72: 1436–1442.

    Article  PubMed  CAS  Google Scholar 

  19. Hegedüs B, Görög S. The polymorphism of cimetidine. J Pharm Biomed Anal. 1985; 3: 303–313.

    Article  PubMed  Google Scholar 

  20. Hancock JD, Sharp JH. Method of comparing solid-state kinetic data and its application to the decomposition of kaolinite, brucite, and BaCO3. J Am Ceram Soc. 1972; 55: 74–77.

    Article  CAS  Google Scholar 

  21. Otsuka M, Kaneniwa N. Dehydration of cephalexin hydrates. Chem Pharm Bull. 1983; 31: 1021–1029.

    CAS  Google Scholar 

  22. Tanigawara Y, Yamakoka K, Nakagawa T, Uno T. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. J Pharm Sci. 1982; 71(10): 1129–1133.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, Kobe Pharmaceutical University, 4-19-1 Motoyama-Kitamachi, 658, Higashi-Nada, Kobe, Japan

    Makoto Otsuka, Fumie Kato & Yoshihisa Matsuda

Authors
  1. Makoto Otsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fumie Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshihisa Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Makoto Otsuka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Otsuka, M., Kato, F. & Matsuda, Y. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry. AAPS PharmSciTech 3, 30 (2002). https://doi.org/10.1208/pt030430

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt030430

Keywords

Search

Navigation